This biotech company may be on the verge of a boom – but they only want pro-life investors
AVM Biotechnology's founder explains their cutting edge – and moral – research.
•
You have not enabled cookies! This site requires cookies to operate properly. Please enable cookies, and refresh your browser for full functionality.